- Home
- VC vs RARE Comparison
VC vs RARE Comparison
Compare VC & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VC | RARE |
|---|---|---|
| Founded | 2000 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VC | RARE |
|---|---|---|
| Price | $100.75 | $24.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 19 |
| Target Price | ★ $126.00 | $73.11 |
| AVG Volume (30 Days) | 528.7K | ★ 2.5M |
| Earning Date | 02-19-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.17 | N/A |
| Revenue | ★ $3,759,000,000.00 | $630,598,000.00 |
| Revenue This Year | N/A | $20.38 |
| Revenue Next Year | $3.22 | $19.02 |
| P/E Ratio | $9.04 | ★ N/A |
| Revenue Growth | N/A | ★ 20.63 |
| 52 Week Low | $65.10 | $18.41 |
| 52 Week High | $129.10 | $46.50 |
Technical Indicators
Market Signals| Indicator | VC | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 47.12 |
| Support Level | $89.68 | $23.76 |
| Resistance Level | $102.51 | $25.82 |
| Average True Range (ATR) | 3.06 | 1.00 |
| MACD | 1.06 | 0.42 |
| Stochastic Oscillator | 81.84 | 72.12 |
Price Performance
Historical ComparisonAbout VC Visteon Corporation
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.